Introduction
Systemic Arterial Hypertension (SAH) is a public health problem that is characterized by a high prevalence and low treatment adherence rate, which is one of the major modifiable risk factors for Cardiovascular Diseases (CVDs). The main goal of treating SAH is to reduce cardiovascular morbidity and mortality (1) .
According to the World Health Organization (WHO), 17 .3 million people died from CVDs in 2008, with 9.4 million of these deaths being due to complications arising from SAH in the same period. In addition, it is estimated that more than 23 million people will die as a result of CVDs by 2030 (2) (3) .
One of the most important factors for effectively controlling Blood Pressure (BP) is patient adherence to treatment, given that 40 to 60% of patients with SAH do not use medication for such (4) . Studies have shown that non-adherence to medication treatment, which is associated with medicine costs and patient sociodemographic conditions, is one of the main explaining factors for people demanding emergency services (5) .
There are many factors that can explain such non-adherence to SAH treatment, which makes it a complex and multidetermined phenomenon (2) . These patients often have lower incomes, have difficulties accessing services, consume greater quantities of alcohol and undertake irregular medical follow-ups (2, 6) . Thus, identifying non-adherence to antihypertensive treatment, as well as factors related to this condition, can make developing an intervention plan possible.
The objective of this plan was to enhance adherence to treatment, reduce complications caused by SAH and decrease hospitalization numbers, which can reduce costs that have to be covered by the health system. Therefore, this study's objective was to identify the epidemiological profile, the existing understanding regarding the disease and the barriers for non-adherence to the treatment by patients with SAH, who had been hospitalized in the emergency room of a university hospital.
Methods
This cross-sectional study was performed from The non-probabilistic intentional sample was made up of 116 patients who had been hospitalized for more than 24 hours in the Emergency Service. These patients had to have had some kind of clinical or surgical diagnosis and personal history of SAH and been in drug treatment for at least one month. The patients were both male and female, aged over 18 years and had no cognitive impairment.
The researcher collected data from these patients by means of a questionnaire. The researcher read all the questions from the questionnaire to each patient in one meeting, with the mean time taken per interview being 25 minutes.
The variables studied were: age, gender, skin color, personal and family income, existence of associated diseases, physical activity level, weight, height, abdominal circumference, consumption of alcoholic beverages and understanding regarding the disease.
Any singular individual was classified as being physically active when he/she communicated undertaking aerobic physical activity such as: walking, running, cycling, dancing, swimming, at a 3 to 5 times a week frequency, with a 30-minute minimum duration (1) .
Weight and height data were collected verbally from the patient, the abdominal circumference was measured using a tape measure at the umbilical line level.
Alcoholic beverage consumption was considered excessive when it exceeded 30 g alcohol/day (1) . Vancini-Campanharo CR, Oliveira GN, Andrade TFL, Okuno MFP, Lopes MCBT, Batista REA.
answers; in the medium adhesion group when he/ she gives one or two positive answers; and in the low adhesion group when he/she gives three or four positive answers (7) .
In order to identify the barriers to treatment adherence, from the patients' perspective, the Fisher's exact test or the likelihood ratio test was used.
The considered level of significance was p<0.05.
Results
The mean patient age was 61.5 years old, most of whom were women (55%), with white skin color (55%), married (47%) and retirees or pensioners (63%). With regards to education level, the majority (59%) had not completed primary education. The most common income level was between one and three Brazilian monthly minimum wages (76%).
The most frequently reported comorbidities by patients were: Dyslipidemia (40%) and diabetes mellitus (34%). The number of different classes of medications used by patients to treat SAH ranged from 1 to 5 drugs.
The sociodemographic characteristics and comorbidities of the patients included in this study can be seen in Table 1 . and physical inactivity (88%).
Rev
The rate of patient adherence to treatment and the barriers to this adherence can be seen in Table 2 , as evaluated by the Morisky test and the Brief Medication Questionnaire, respectively.
The majority of patients (56%) presented a medium adherence to treatment, with the main barrier to this adherence being remembering to use the medication (recall), which was found in 67% of patients. In regards to the belief heading, patients with higher heart rates during the evaluation, patients who work from home, retirees/pensioners or the unemployed and physically inactive presented belief barriers regarding the effectiveness of the treatment and its adverse effects. Vancini-Campanharo CR, Oliveira GN, Andrade TFL, Okuno MFP, Lopes MCBT, Batista REA.
Regarding the recall heading, patients who used a larger number of different drugs showed higher recall percentage barriers.
Discussion
In this study, most of the patients were female, had an mean age of 61.5 years and a low education level. These patients had an emergency service demand profile that was similar to other studies conducted with hypertensive patients in first aid units (4, 9) . SAH is more common in men aged up to 50 years (10) , however, whenever more women are observed diagnosed with SAH, it can be explained by the fact that women are more likely to seek health services, with a view to discover the diagnosis of the disease (11) .
Comorbidities diabetes mellitus and Dyslipidemia were present in 34 and 40% of the interviewees during this study, respectively. Besides SAH, the presence of other comorbidities in the patients involved in this study can be linked to bad eating habits and lack of physical activity, which may give rise to the appearance of many chronic illnesses, which are often asymptomatic. Medical treatment, when arranged alongside lifestyle change, is the best way of reducing and preventing the damage generated by these chronic diseases (1) .
As regards the blood pressure levels found in this study, the mean systolic blood pressure was 126.3 This particular study also revealed that the patients treated in the first aid unit reported using controlled salt intake as a measure to control SAH (9) . Despite this similar study having reported this controlled salt intake, it did not describe how the patients controlled the amount of salt in their food (9) . The fact that the mean blood pressure was lower in this similar study may be associated with the respondents having been hospitalized for over 24 hours in the emergency service, where they would have received antihypertensive therapy and restricted sodium intake through the low-sodium diet provided, which, according to the WHO, is 5 g of salt per day or 2 g of sodium (1) .
The Morisky test classified most of the interviewed patients as being in the medium adherence group (56%). The adherence rate found during this study is close to those found in the literature (12) (13) . The medium and low antihypertensive treatment adherence may be associated to age, to using more than one different drugs to control blood pressure, and to lack of supervision and control of the disease (12, 14) . In addition, measuring patient treatment adherence is challenging, since there has been no consensus reached, from among the methods used, regarding which is the best method that can be considered the gold-standard (15) (16) .
In regards to the barriers for non-adherence to treatment, 67% of the patients presented a significant (p<0.0001) barrier in the recall section of the BMQ when the patient was using more than one medication, of any class, to control his/her blood pressure. These data are in line with another study, which pointed out that the main reason for patients' non-adherence was due to them forgetting to use their medication (17) .
These results indicate that the difficulty of patients remembering to take their medication is directly proportional to the number of drugs that they use.
This suggests that monotherapy is a good strategy to encourage adherence to antihypertensive treatment (17) .
Another study, performed at the basic health network in the Southern Region of Brazil, pointed out that the complex pharmacotherapy involved in treating SAH is one of the factors associated with non-adherence to drug treatment, followed by the dissatisfaction with the health service (18) .
The majority of interviewees (88%) reported that they understand that hypertension is a serious illness.
There was an observed significant correlation (p = This study observed that when the medication was provided in full to the patient, there was a higher percentage of treatment adherence. This finding may be related to the low socioeconomic status of the studied population, who has difficulty meeting the treatment costs. One of the factors reported by patients as the reason for stopping their treatment is the high cost of medication associated with the lack of income to buy it, followed by forgetting to use it (9) . In contrast, one international study showed that the level of adherence to medication is higher when medical expenses are lower (19) . Stimulating adherence to proposed treatment is necessary as is raising awareness surrounding the costs of non-adherence to treatment and to its impact on the health system. to health services (17) .
Among men and women with a low educational level, SAH is more common with increasing age, with it being higher for men up to the age of 50 years, which is twice as prevalent among non-whites with a predominance of black women as it is for white individuals (1, 21) .
1155
www.eerp.usp.br/rlae
Vancini-Campanharo CR, Oliveira GN, Andrade TFL, Okuno MFP, Lopes MCBT, Batista REA.
Conclusion
Most of the hypertensive patients admitted to the emergency service were female, with low income and low education. These individuals showed that they had a moderate understanding of the disease and managed moderate treatment adherence, with the main barrier to this adherence being forgetfulness in terms of using their medication. When the medication was fully supplied without charge, the patients showed a higher percentage of treatment adherence. There was high correlation between the number of drugs used and the recall barrier, which suggests that monotherapy is an option that can facilitate treatment adherence and, in cases where this is not possible, it is necessary that the health team jointly look into other strategies with the patient so as to reduce how often the patients forget to take their medication.
There is no consensus in the literature regarding the best method to evaluate adherence to drug treatment.
Direct methods, such as taking blood samples are costly and difficult to execute; indirect methods, such as questionnaires, can be considered and their results compared with studies that used other strategies. There is no method that is considered excellent, with the use of combined approaches often being required.
